Global Market for Acute Heart Failure (AHF) Therapeutics
Acute Heart Failure (AHF) Therapeutics Global Strategic Business Report 2022-2024 and 2030 - The Litany of Drug Failures Expands, Emphasis on Prevention Grows
March 01, 2024 06:25 ET | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Acute Heart Failure (AHF) Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Acute...
22157.jpg
Cardiac Resynchronization Therapy Market Set To Grow, New Study Reveals Key Drivers and Trends Shaping the Future
February 15, 2024 12:04 ET | Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Resynchronization Therapy Market Report by Type, Application, End User, and Region 2023-2028" report has been added to ...
Global Artificial Intelligence In Cardiology Market
Artificial Intelligence in Cardiology Market Set for Rapid Growth, Forecast 2024-2034: Emphasis on Advanced Diagnostic Solutions with CAGR of 34.14%
January 29, 2024 06:05 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence In Cardiology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Cardiovascular Perfusion Disposables Market: Rapid Growth Forecast Revealed till 2033
January 24, 2024 01:48 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Daxor logo thumbnail.png
New Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure Patients
November 13, 2023 08:00 ET | Daxor Corporation
Data From Study Funded by NIH Presented at the American Heart Association Annual Meeting Oak Ridge, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
Optimizer® Smart Mini System
Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System
October 30, 2023 11:37 ET | Impulse Dynamics
MARLTON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has received...
Ventricle Health Workmark.png
Ventricle Health secures $8M in seed financing led by RA Capital Management, along with Waterline Ventures and others to accelerate national delivery of its value-based home care model for heart failure patients
October 17, 2023 09:30 ET | Ventricle Health
Ventricle Health secures $8M in seed financing to accelerate national delivery of its value-based home care model for heart failure patients.
22157.jpg
Cardiovascular Disease Prevalence Sparks Demand in Global Perfusion Disposables Market - Report Analyzes Market Insights Across 39 Countries with Focus on Valvular Health
October 17, 2023 06:53 ET | Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures...
22157.jpg
Heart Failure Epidemiology Analysis and Forecast to 2032: Focus on 7 Major Markets - US, France, Germany, Italy, Spain, UK, and Japan
October 09, 2023 09:53 ET | Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Heart Failure Epidemiology Analysis and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Daxor logo thumbnail.png
JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®
August 10, 2023 08:00 ET | Daxor Corporation
Researchers Call for Larger Clinical Trial Citing Outcomes from Study Oak Ridge, TN, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...